Back to Search
SUSAN PITT, MD
MD
Surgery Physician
NPI: 1588891329IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
EMC0000931(MI)
CMS Specialties
PrimaryGENERAL SURGERY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 2005
Research & Publications (20)
Argininamide binding arrests global motions in HIV-1 TAR RNA: comparison with Mg2+-induced conformational stabilization.
PMID 15050819·J Mol Biol·2004
4-observational
Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.
PMID 19588205·Ann Surg Oncol·2009
8-other
Follicular thyroid cancer cell growth inhibition by proteosome inhibitor MG132.
PMID 19552924·J Surg Res·2009
8-other
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
PMID 19651067·J Am Coll Surg·2009
8-other
Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.
PMID 19372564·Mol Cancer Ther·2009
8-other
Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate?
PMID 19548038·J Gastrointest Surg·2009
4-observational
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
PMID 18364256·Bioorg Med Chem Lett·2008
7-preclinical
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.
PMID 18516757·Curr Opin Investig Drugs·2008
6-review
Hepatic neuroendocrine metastases: chemo- or bland embolization?
PMID 18709512·J Gastrointest Surg·2008
4-observational
The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer.
PMID 19081012·Surgery·2008
6-review
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
PMID 18359226·Bioorg Med Chem Lett·2008
8-other
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor.
PMID 18313298·Bioorg Med Chem Lett·2008
7-preclinical
Benzothiazole based inhibitors of p38alpha MAP kinase.
PMID 18296051·Bioorg Med Chem Lett·2008
7-preclinical
High intracellular chloride slows the decay of glycinergic currents.
PMID 18987182·J Neurosci·2008
7-preclinical
Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
PMID 18072718·J Med Chem·2008
7-preclinical
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds.
PMID 17664068·Bioorg Med Chem Lett·2007
8-other
2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor.
PMID 17154512·J Med Chem·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR, 2ND FLOOR TAUBMAN CENTER RECP F
ANN ARBOR, MI 48109 - Phone
- (734) 936-5738
Quick Facts
- NPI
- 1588891329
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile